HOULIHAN LOKEY ($HLI) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $1.84 per share, beating estimates of $1.72 by $0.12. The company also reported revenue of $659,450,000, beating estimates of $654,626,278 by $4,823,722.
You can see Quiver Quantitative's $HLI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HOULIHAN LOKEY Insider Trading Activity
HOULIHAN LOKEY insiders have traded $HLI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $HLI stock by insiders over the last 6 months:
- PAUL ERIC SIEGERT (CO-CHAIRMAN) sold 40,000 shares for an estimated $7,998,000
- IRWIN GOLD (CO-CHAIRMAN) has made 0 purchases and 2 sales selling 11,811 shares for an estimated $2,294,980.
- SCOTT L BEISER (CO-CHAIRMAN) sold 8,008 shares for an estimated $1,431,109
- CHRISTOPHER M CRAIN (GENERAL COUNSEL) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $184,620.
- GILLIAN BETH ZUCKER has made 0 purchases and 3 sales selling 600 shares for an estimated $108,896.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
HOULIHAN LOKEY Hedge Fund Activity
We have seen 275 institutional investors add shares of HOULIHAN LOKEY stock to their portfolio, and 252 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAYFLOWER FINANCIAL ADVISORS, LLC added 1,121,832 shares (+inf%) to their portfolio in Q3 2025, for an estimated $230,334,546
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 361,085 shares (+194.9%) to their portfolio in Q2 2025, for an estimated $64,977,245
- THRIVENT FINANCIAL FOR LUTHERANS removed 353,812 shares (-98.4%) from their portfolio in Q2 2025, for an estimated $63,668,469
- CAPITAL RESEARCH GLOBAL INVESTORS added 294,781 shares (+58.5%) to their portfolio in Q2 2025, for an estimated $53,045,840
- RENAISSANCE GROUP LLC added 189,583 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,115,460
- ASSENAGON ASSET MANAGEMENT S.A. removed 182,729 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $37,517,918
- EARNEST PARTNERS LLC removed 176,439 shares (-6.7%) from their portfolio in Q2 2025, for an estimated $31,750,198
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
HOULIHAN LOKEY Congressional Stock Trading
Members of Congress have traded $HLI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HLI stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 06/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
HOULIHAN LOKEY Analyst Ratings
Wall Street analysts have issued reports on $HLI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BMO Capital issued a "Outperform" rating on 10/03/2025
- Morgan Stanley issued a "Overweight" rating on 09/08/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/14/2025
- Wells Fargo issued a "Overweight" rating on 07/11/2025
To track analyst ratings and price targets for HOULIHAN LOKEY, check out Quiver Quantitative's $HLI forecast page.
HOULIHAN LOKEY Price Targets
Multiple analysts have issued price targets for $HLI recently. We have seen 6 analysts offer price targets for $HLI in the last 6 months, with a median target of $211.5.
Here are some recent targets:
- Alex Bond from Keefe, Bruyette & Woods set a target price of $226.0 on 10/13/2025
- Nathan Stein from Deutsche Bank set a target price of $210.0 on 10/09/2025
- Brennan Hawken from BMO Capital set a target price of $230.0 on 10/03/2025
- Ryan Kenny from Morgan Stanley set a target price of $213.0 on 09/08/2025
- Michael Brown from Wells Fargo set a target price of $209.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
